Retraction to: Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL: miR-708 and Its Targets in Childhood B-ALL (Pediatric Blood & Cancer, (2013), 60, 12, (2060-2067), 10.1002/pbc.24583);Overexpression of miR-708 and its targets in the childhood common precursor B-cell ALL

Pediatric Blood and Cancer

Volumn 60, Issue 12, 2013, Pages 2060-2067

  Li, Xue ^a   Li, Dong ^a   Zhuang, Yong ^a   Shi, Qing ^a   Wei, Wei ^a   Ju, Xiuli ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

MiRNA; Pediatric acute lymphoblastic leukemia; Regulatory region; Target gene

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GNG12 PROTEIN; LUCIFERASE; MICRORNA; MICRORNA 27A; MICRORNA 345; MICRORNA 708; MIRNA 181B; NEUROTROPHIC FACTOR; NNAT PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BIOINFORMATICS; CANCER RISK; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BINDING; FEMALE; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; PRE B LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; UPREGULATION;

EID: 84885749110     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.26498     Document Type: Erratum

References (25)

1. Pui CH, Campana D, Evans WE. Childhood acute lymphoblastic leukemia-Current status and future perspectives. Lancet Oncol 2010; 2:597-607.
2. Uzunel M, Jaksch M, Mattsson M, et al. Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia. Br J Hematol 2003; 122:788-794.
3. Coustan SE, Sancho J, Hancock ML, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood 2000; 96:2691-2696.
4. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303:83-86.
5. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297.
6. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
7. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Natl Acad Sci 2002; 99:15524-15529.
8. Pedro PM, Mona N, Frank JS. OncomiR addiction in an in vivo model of microRNA-21 induced pre-B-cell lymphoma. Nature 2010; 467:86-92.
9. Mavrakis KJ, Van Der Meulen J, Wolfe AL, et al. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet 2011; 43:673-678.
10. Schotte D, Akbari Moqadam F, Lange-Turenhout EAM, et al. Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia. Leukemia 2011; 25:1389-1399.
11. Schotte D, Pieters R, Den Boer ML. MicroRNAs in acute leukemia: From biological players to clinical contributors. Leukemia 2012; 26:1-12.
12. Gao C, Zhao XX, Li WJ, et al. Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: A single institutional study of 1, 004 patients. Am J Hematol 2012; 87:1022-1027.
13. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucl Acids Res 2005; 33:e179.
14. Zheng L, Baumann U, Reymond JL. An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucl Acids Res 2004; 32:e115.
15. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15-20.
16. Kotani A, Ha D, Hsieh J, et al. miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221. Blood 2009; 114:4169-4178.
17. Ju XL, Li D, Shi Q, et al. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. Pediatr Hematol Oncol 2009; 26:1-10.
18. Zhang H, Luo XQ, Zhang P, et al. MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS ONE 2009; 4:e7826.
19. Han BW, Feng DD, Li ZG, et al. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Hum Mol Genet 2011; 20:4903-4915.
20. Nancy YI, Steven HN, Teri GB, et al. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell 1992; 69:1121-1132.
21. David W, Sternberg DW, Gilliland DG. The role of signal transducer and activator of transcription factors in leukemogenesis. J Clin Oncol 2004; 22:361-371.
22. Evans HK, Wylie AA, Murphy SK, et al. The neuronatin gene resides in a micro-imprinted domain on human chromosome 20q11.2. Genomics 2010; 77:99-104.
23. Steven JK, Joshua P, Alison W, et al. Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemia. Carcinogenesis 2002; 23:559-564.
24. Kelley CL, Michael PD, Maciej L, et al. Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2. Inflamm Res 2010; 59:15-22.
25. Karreth FA, Tay Y, Perna D, et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 2011; 147:382-395.